Biolevate
Biolevate is a VC-backed B2B startup harnessing the power of AI to deliver therapeutics innovation faster to market thanks to an all-in-one SaaS platform.
Funding
Every round, secondary, debt facility or acquisition involving Biolevate that AI Lounge tracks, newest first. Latest: Series A on Sep 21, 2026.
Timeline · 2
In the news
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in